* DNA Plant Technology Corp., of Oakland, Calif.,raised $1.9 million in a private placement of 2 millionrestricted shares and warrants to purchase another 1.2million shares. The company said the placement is part ofan agreement to sell up to 9.7 million restricted sharesand warrants for another 5 million shares during the thirdquarter.
* LeuKoSite Inc., of Cambridge, Mass., expanded its1994 collaboration with Warner-Lambert Co., of MorrisPlains, N.J., to develop small molecule inhibitors ofchemokines, which are believed to be involved ininflammatory and autoimmune diseases. The newagreement will focus on blockers for interleukin-8. Nofinancial terms were released.
(c) 1997 American Health Consultants. All rights reserved.